Nilai Buku saben Saham: Tempus (TEM)

Tempus AI, Inc. (TEM) - logo korporat

Tempus AI, Inc (TEM) is aggressively expanding its network of partnerships with clinics for data collection. After evaluating the bps metric on GURU.Markets, we find that the value 2.45 captures this indicator. Visionary management is effectively monetizing genomic databases, while strict cold-chain logistics for biosamples ensure diagnostic accuracy despite rising operating expenses.

Ekuitas saben Saham Tempus (TEM): kanggo periode 15.06.2024 - 27.10.2026
Produk asli Tempus Labs

The investment appeal of Tempus AI, Inc (TEM) is based on the monetization of unique molecular data sets for the pharmaceutical industry. This indicator is calculated as the difference between all assets and liabilities, divided by the number of shares. The trend in net assets per share reflects the real value of the business's tangible fundamentals. For an AI company, this metric confirms the capitalization of intellectual property. Growth in this metric signals an increase in the company's internal stability.

Analisis pesaing Tempus AI, Inc

QGEN: Aset Bersih saben Siji Saham|IONS - Nilai Akuntansi saben Saham|Nilai Buku saben Saham Repligen Corporation|RNA (aviditybiosciences.com) - Ekuitas saben Saham|Aset Bersih saben Siji Saham CRISPR Therapeutics (CRSP)|Ekuitas saben Saham GeneDx Holdings|Nilai Buku saben Saham RARE|Nilai Buku saben Saham Beam Tx BEAM|Nilai Akuntansi saben Saham Sarepta Therapeutics, Inc. (SRPT)|Rega Buku Saham twistbioscience.com TWST|TXG (10x Genomics) - Nilai Buku saben Saham|NTLA: Nilai Aset Bersih saben Saham|STOK (Stoke) - Aset Bersih saben Siji Saham|BLFS (BioLife) - Nilai Akuntansi saben Saham|Aset Bersih saben Siji Saham Wave Life Sciences WVE|Nilai Buku Saham mazetx.com (MAZE)|Nilai Akuntansi saben Saham SION|Nilai Buku saben Saham PRME (Prime Medicine Inc)|Aset Bersih saben Siji Saham TSHA|QURE - Aset Bersih saben Saham|Nilai Akuntansi saben Saham MeiraGTx Holdings plc (MGTX)|RGNX - Nilai Akuntansi Saham|SLDB: Nilai Buku saben Saham|Ocugen Inc (OCGN) - Nilai Buku saben Saham|PACB: Nilai Buku saben Saham|Aset Bersih saben Saham Benitec Corp (BNTC)|Design Therapeutics (DSGN) - Nilai Akuntansi saben Saham|Nilai Akuntansi Saham rocketpharma.com (RCKT)|Nilai Buku saben Saham FDMT|Lexeo Therapeutics Inc. - Aset Bersih saben Saham|Korro Bio, Inc (KRRO) - Aset Bersih saben Siji Saham|EDIT - Ekuitas saben Saham|SLN (Silence Therapeutics) - Nilai Buku saben Saham|Nilai Akuntansi saben Saham ProQR Therapeutics|Codexis Inc (CDXS) - Nilai Akuntansi saben Saham|Rega Buku Saham Sangamo Therapeutics Inc.|Nautilus Biotechnology - Nilai Buku saben Saham|Nilai Aset Bersih saben Saham MGX (Metagenomi Therapeutics)|Precision BioSciences, Inc. - Aset Bersih saben Siji Saham|Nilai Akuntansi saben Saham Generation Bio Co GBIO|Boundless Bio (BOLD) - Nilai Buku saben Saham|XCUR: Ekuitas saben Saham|Aset Bersih saben Siji Saham imunon.com|Phio Pharmaceuticals Corp. (PHIO) - Ekuitas saben Saham|MBIO (Mustang Bio Inc) - Nilai Buku saben Saham|Nilai Buku saben Saham TransCode (RNAZ)|Nilai Akuntansi saben Saham Bionano Genomics, Inc.|Rega Buku Saham Applied DNA Sciences Inc (APDN)|BLUE: Nilai Buku saben Saham|ImmunoPrecise Antibodies Ltd - Nilai Aset Bersih saben Saham|OMGA: Aset Bersih saben Siji Saham|OMIC: Nilai Akuntansi saben Saham|Aset Bersih saben Siji Saham Regulus Therapeutics Inc. (RGLS)|Nilai Buku Saham Syros Pharmaceuticals Inc.|TBIO (Codex DNA) - Nilai Akuntansi saben Saham|Nilai Buku saben Saham TCON|UBX (Unity Biotechnology) - Aset Bersih saben Siji Saham